Shining a Light on IL-13: Optimizing Moderate-to-Severe Atopic Dermatitis Treatment in Daily Practice: An Online Activity

Shining a Light on IL-13: Optimizing Moderate-to-Severe Atopic Dermatitis Treatment in Daily Practice: An Online Activity is organized by Dermsquared .

Release Date: April 17, 2025
Expiration Date: October 18, 2026

Learning Objectives

At the completion of this activity, participants should be better able to:

• Differentiate biologic therapies targeting IL-13 based on their clinical profile
• Review emerging clinical data for IL-13 biologics in the treatment of moderate-to-severe AD
• Identify patients with moderate-to-severe AD eligible for biologic therapy according to the 2023 American Academy of Dermatology guidelines